| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |